OS Therapies' (OSTX) Buy Rating Reiterated at D. Boral Capital

Key Points

• OS Therapies (OSTX) has had its "buy" rating reiterated by D. Boral Capital, with a target price set at $20.00.
• The stock opened at $2.01, has a market capitalization of $63.61 million, and a P/E ratio of -2.54.
• Recent institutional investments include CM Management increasing its stake by 172.6%, owning now 300,000 shares valued at approximately $462,000.

OS Therapies (NYSE:OSTX - Get Free Report)'s stock had its "buy" rating reiterated by stock analysts at D. Boral Capital in a report issued on Tuesday,Benzinga reports. They currently have a $20.00 target price on the stock.

OS Therapies Stock Performance

OSTX opened at $2.01 on Tuesday. The stock has a market capitalization of $63.61 million and a P/E ratio of -2.54. The company's 50-day simple moving average is $2.07 and its two-hundred day simple moving average is $1.81. OS Therapies has a 52-week low of $1.12 and a 52-week high of $7.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of OSTX. CM Management LLC lifted its position in OS Therapies by 172.6% in the first quarter. CM Management LLC now owns 300,000 shares of the company's stock worth $462,000 after buying an additional 189,956 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of OS Therapies in the 2nd quarter worth approximately $63,000. Finally, Bridgeway Capital Management LLC purchased a new stake in shares of OS Therapies during the second quarter worth about $47,000.

About OS Therapies

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.